全文获取类型
收费全文 | 5939篇 |
免费 | 535篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 93篇 |
儿科学 | 207篇 |
妇产科学 | 102篇 |
基础医学 | 845篇 |
口腔科学 | 76篇 |
临床医学 | 765篇 |
内科学 | 930篇 |
皮肤病学 | 95篇 |
神经病学 | 706篇 |
特种医学 | 229篇 |
外国民族医学 | 1篇 |
外科学 | 889篇 |
综合类 | 97篇 |
一般理论 | 3篇 |
预防医学 | 589篇 |
眼科学 | 104篇 |
药学 | 387篇 |
中国医学 | 6篇 |
肿瘤学 | 362篇 |
出版年
2023年 | 83篇 |
2022年 | 122篇 |
2021年 | 280篇 |
2020年 | 174篇 |
2019年 | 251篇 |
2018年 | 280篇 |
2017年 | 199篇 |
2016年 | 198篇 |
2015年 | 232篇 |
2014年 | 289篇 |
2013年 | 333篇 |
2012年 | 443篇 |
2011年 | 441篇 |
2010年 | 235篇 |
2009年 | 205篇 |
2008年 | 299篇 |
2007年 | 284篇 |
2006年 | 242篇 |
2005年 | 196篇 |
2004年 | 193篇 |
2003年 | 140篇 |
2002年 | 132篇 |
2001年 | 70篇 |
2000年 | 84篇 |
1999年 | 69篇 |
1998年 | 39篇 |
1997年 | 26篇 |
1996年 | 21篇 |
1995年 | 25篇 |
1992年 | 61篇 |
1991年 | 58篇 |
1990年 | 41篇 |
1989年 | 46篇 |
1988年 | 46篇 |
1987年 | 29篇 |
1986年 | 38篇 |
1985年 | 64篇 |
1984年 | 48篇 |
1983年 | 25篇 |
1982年 | 25篇 |
1981年 | 26篇 |
1979年 | 24篇 |
1974年 | 21篇 |
1972年 | 21篇 |
1971年 | 25篇 |
1970年 | 24篇 |
1969年 | 23篇 |
1968年 | 20篇 |
1967年 | 19篇 |
1965年 | 21篇 |
排序方式: 共有6486条查询结果,搜索用时 8 毫秒
1.
2.
3.
4.
Syntheses of several tripeptide analogues of leupeptin containing C-terminal argininal, lysinal, or ornithinal units are presented. The synthetic analogues were tested as inhibitors of trypsin, plasmin, and kallikrein. (Benzyloxycarbonyl)-L-leucyl-L-leucyl-L-argininal (2a) was significantly less effective as an inhibitor of trypsin and plasmin activity than leupeptin. (Benzyloxycarbonyl)-L-leucyl-L-leucyl-L-lysinal (2e) and (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-ornithinal (2i) display different inhibition characteristics than (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-argininal (2a). While (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-argininal (2a) showed moderate inhibition of all three enzymes tested, (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-lysinal (2e) was less effective as an inhibitor of trypsin and plasmin activity. Of the three enzymes tested, (benzyloxycarbonyl)-L-leucyl-L-leucyl-L-ornithinal (2i) showed significant inhibition of kallikrein activity only. Modifications made in the composition and sequence of the P2 and P3 amino acids also resulted in variations in the inhibitory activity of the analogues. In general, plasmin showed a strong preference for inhibitors which contain an L-phenylalanyl-L-leucyl or an L-leucyl-L-valyl unit in the P2 and P3 positions. 相似文献
5.
6.
The techniques specific to peroperative fluorocholangiography are discussed based on an experience of 632 cholangiograms and an estimation has been made of the associated radiation doses to staff and patients. Rapid and accurate information can be obtained during fluorocholangiography using appropriate techniques with acceptably low radiation hazards. 相似文献
7.
8.
Valery L Feigin Craig S Anderson Anthony Rodgers Neil E Anderson Alistair J Gunn 《Journal of clinical neuroscience》2002,9(5):502-507
Current treatment of acute stroke remains unsatisfactory. This review presents experimental and clinical data which suggest that mild induced hypothermia could be a potent and practicable neuroprotective treatment of acute ischaemic stroke and intracerebral haemorrhage. Hypothermia, if proven to be safe, effective and widely practicable in patients with acute stroke, could have an enormous positive impact on reducing the burden of stroke worldwide. Critical issues that will need to be considered in a well designed randomised controlled trial of induced hypothermia in acute stroke patients are discussed. 相似文献
9.
This study looked at the prevalence of panic attacks and panic disorder in a British population. Three thousand people (aged 18-65) registered with a Leicester general practice were sent a postal questionnaire which screened for panic attacks. Where appropriate this was followed by a diagnostic interview. Preliminary results are reported for the first 1500 subjects sampled. Panic attacks are a common experience in the study population (7.5% of responders experienced them around the time of the interview). Panic disorder was diagnosed in about 3% of responders. 相似文献
10.
A A Abitbol J G Schwade A A Lewin K Sridhar A H Brandon A M Markoe R R Casiano P V Houdek C Serago D J Miller 《American journal of clinical oncology》1992,15(3):250-255
Seventeen patients were entered into a Phase I/II trial of concurrent hyperfractionated radiation therapy (7,440 cGy total dose; 120 cGy b.i.d.) combined with constant infusion of 5-fluorouracil (5-FU) (1,000 mg/m2/24 hours for 72 hours) and cisplatin (DDP) (50 mg/m2) for a total of three cycles. Thirteen patients had Stage IV disease; three, Stage III disease; and one, Stage II hypopharyngeal disease. Thirteen of 17 patients had positive cervical lymph nodes, and the mean size of the largest lymph node was 5.5 x 5.1 cm. The patients were not treated with planned adjunctive surgery except for one patient who had a radical neck dissection for massive, rapidly growing cervical adenopathy, which recurred promptly within 1 month before the initiation of protocol therapy. After the initial six patients were entered, mitomycin-C (Mito 8 mg/m2) was added during the second cycle. All the patients completed the planned course of radiotherapy with a median dose of 7,440 cGy and a mean dose of 7,248 cGy except for two patients who died--one from toxicity and the other, suicide. The predominant toxicity was mucositis, which was grade 3/4 in 11 of 15 patients, resulting in an average interruption of radiation therapy of 12 days. Weight loss was significant and was on the average 12% of baseline weight. Hematological toxicity was mild in the 5-FU/DDP group (only one grade 3 toxicity of six) and severe in the 5-FU/DDP/Mito-treated patients (five of eight patients having grade 3/4 toxicity including one leukopenic pneumonitis death). Additional toxicity included one parapharyngeal cellulitis, which responded to antibiotics. Noncompliance with the complex regimen was only seen in three patients. One patient refused b.i.d. radiation therapy, and one patient refused further chemotherapy after the first cycle. Additionally, one patient who had a severe ethanol withdrawal reaction during the first cycle of 5-FU/DDP did not receive further chemotherapy. The complete response rate of both primary site and neck by the protocol regimen alone was 71%. However, two patients, one from each group, did undergo salvage neck dissection, and the locoregional control is currently 73%, with a mean follow-up time of 18.4 months. The feasibility of combining hyperfractionated radiation therapy with aggressive concurrent chemotherapy was demonstrated. The response and local control rate justifies the added toxicity of concurrent chemotherapy and radiation therapy. 相似文献